How to succesfuly manage tenders and big deals in medtech
Simon-Kucher Perspectives
How to Successfully Manage Tenders and Big Deals in Medtech
chc
Success Story
Assess Commercial Viability of a Dual Brand Strategy for Branded CHC Manufacturer
Digitalization in the life sciences industry
Blog post
Digitalization in the Life Sciences Industry
Healthcare Insights
Simon-Kucher Perspectives
Healthcare Insights, January 2018
Video
Simon-Kucher Expert Talk: Drug Pricing and Market Access
Medtech barometer 2016
Simon-Kucher Perspectives
Medtech Barometer 2016
Medtech Barometer 2017
Simon-Kucher Perspectives
Medtech Barometer 2017
Stepping down value to enhance TopLine Power®
Blog post
Stepping Down Value to Enhance TopLine Power®
sales excellence - healthcare insights
Blog post
What Sales Champions Do Differently – 4 Key Success Factors
Three ways OTC manufacturers can boost their bottom-line
Simon-Kucher Perspectives
Three Ways OTC Manufacturers Can Boost Their Bottom Line
Why consumer healthcare companies need to look into European price management NOW
Simon-Kucher Perspectives
Why Consumer Healthcare Companies Need to Look Into European Price Management NOW
Winning Tenders
Blog post
Wising Up on Intelligence Gathering to Win Medtech Tenders
Digital Health Solutions
Simon-Kucher Perspectives
Monetizing Digital Health Solutions - An opportunity or burden for the industry?
MonetizingPharma
Simon-Kucher Perspectives
Monetizing Innovations in the Pharma and Biotech Industry
consumer healthcare
Simon-Kucher Perspectives
Increasing Profits Through Structured Consumer Pricing
healthcare brand strategy
Simon-Kucher Perspectives
A Second Brand Strategy in the Healthcare Area
Innovation in biotech
Blog post
Differing Priorities: Spurring Innovation Versus Rewarding It
drug reimbursement - simon-kucher
Blog post
Post-negotiation Reimbursed Prices in China
Pharmind_news
Blog post
Pharmaceutical Industry: Organization of the Pricing and Market Access Function
Dental care industry analysis 2013
Simon-Kucher Perspectives
Dental Care Industry Analysis 2013
Healthcare insights
Simon-Kucher Perspectives
Healthcare Insights – Winter 2017
healthcare products
Success Story
Key Account Growth Strategy for Leading Healthcare Products Manufacturer
Sales growth
Blog post
Tax Overhaul Creates Strategic Decision Point for US Life Science Companies
Will Pharma be "Singing the Blues" or is it just "Fake News"?
Blog post
Will Trump’s Blueprint Have Pharma Singing the Blues or Is It Just Fake News?
FDA's breakthrough therapy designation
Simon-Kucher Perspectives
The FDA's Breakthrough Therapy Designation
chc
Success Story
Optimized Trade Terms for Leading Consumer Healthcare Manufacturer
pharmacy
Success Story
Sales-force Optimization for Large Global Pharmaceutical Company
AskThePayer
Blog post
Digital Pill Excitement: Do Payers Share the Same Sentiment?
Monetizing Digital Therapeutics
Blog post
Monetizing Digital Therapeutics
Global Pricing Study 2016 - Medtech industry focus
Simon-Kucher Perspectives
Global Pricing Study 2016 – Medtech Industry Focus
life sciences
Success Story
Payer Contracting Framework for Global Pharma Player
life sciences
Success Story
Sales Force Optimization for Leading Manufacturer of Medical Devices
HealthcareInsights
Blog post
Greater Reimbursement Opportunities for Innovative Therapies in China – An Analysis of 2017 National Drug Price Negotiations
pills popping out of a bottle
Simon-Kucher Perspectives
The UK Cancer Drugs Fund
How to maximize the ROI of your trade investments
Simon-Kucher Perspectives
How to Maximize the ROI of Your Trade Investments
chc
Success Story
Annual Profit Impact of More Than USD 4m With Structured Value Pricing Approach for CHC Manufacturer
HCI - Simon-Kucher
Simon-Kucher Perspectives
Healthcare Insights - July 2017
HealthcareInsights
Blog post
Barbec(EU)’d Oncology Market Access – Part D(EU)x
International price referencing for Medicare Part B: What would be the impact on top Medicare Part B drugs by spend?
Blog post
International price referencing for Medicare Part B: What would be the impact on top Medicare Part B drugs by spend?